Lin, Han-WeiHan-WeiLinFu, Chi-FengChi-FengFuChang, Ming-ChengMing-ChengChangTZU-PIN LULin, Hsiu-PingHsiu-PingLinYING-CHENG CHIANGCHI-AN CHENWEN-FANG CHENG2019-02-202019-02-202018-111750-1911https://scholars.lib.ntu.edu.tw/handle/123456789/403808To investigate the CDH1, DLEC1 and SFRP5 gene methylation panel for advanced epithelial ovarian carcinoma (EOC).enCDH1; DLEC1; SFRP5; TCGA dataset; advanced stage; capillary electrophoresis; epithelial ovarian cancer; gene methylation; methylation-specific PCR; prognostic biomarker[SDGs]SDG3antineoplastic metal complex; dlec1 protein; membrane protein; paclitaxel; secreted frizzled related protein 5; tumor marker; unclassified drug; uvomorulin; cadherin; CDH1 protein, human; DLEC1 protein, human; eye protein; leukocyte antigen; membrane protein; SFRP5 protein, human; tumor marker; tumor suppressor protein; adjuvant chemotherapy; adult; advanced cancer; Article; cancer combination chemotherapy; cancer mortality; cancer patient; cancer prognosis; cancer recurrence; cancer survival; cancer tissue; capillary electrophoresis; clear cell carcinoma; clinical evaluation; clinical outcome; cohort analysis; controlled study; disease free survival; DNA methylation; endometrioid carcinoma; female; gene frequency; histopathology; human; human tissue; major clinical study; middle aged; ovary adenocarcinoma; ovary carcinoma; overall survival; priority journal; survival analysis; survival rate; aged; genetics; ovary tumor; pathology; Adult; Aged; Antigens, CD; Biomarkers, Tumor; Cadherins; Carcinoma, Ovarian Epithelial; DNA Methylation; Eye Proteins; Female; Humans; Membrane Proteins; Middle Aged; Ovarian Neoplasms; Survival Analysis; Tumor Suppressor Proteinsjournal articlehttps://api.elsevier.com/content/abstract/scopus_id/8505631851810.2217/epi-2018-0035303248022-s2.0-85056318518WOS:000452399300004https://api.elsevier.com/content/abstract/scopus_id/85056318518